Novanta Inc - Asset Resilience Ratio

Latest as of September 2018: 0.00%

Novanta Inc (NOVT) has an Asset Resilience Ratio of 0.00% as of September 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check strategic asset allocation of Novanta Inc to assess the company's strategic physical and investment asset allocation.

Liquid Assets

$0.00
Cash + Short-term Investments

Total Assets

$759.44 Million
All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (1998–2017)

This chart shows how Novanta Inc's Asset Resilience Ratio has changed over time. See net asset quality index of Novanta Inc to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Novanta Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Novanta Inc worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $0.00 0%
Total Liquid Assets $0.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: Novanta Inc maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

Novanta Inc Industry Peers by Asset Resilience Ratio

Compare Novanta Inc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Wuhan Jingce Electronic Technology Co Ltd
SHE:300567
Scientific & Technical Instruments 0.68%
Chengdu RML Technology Co. Ltd.
SHE:301050
Scientific & Technical Instruments 22.52%
SMS Electric Co Ltd Zhengzhou
SHE:002857
Scientific & Technical Instruments 22.98%
Catapult Group International Ltd
AU:CAT
Scientific & Technical Instruments 6.17%
Ikegps Group Ltd
AU:IKE
Scientific & Technical Instruments 22.52%
Optiscan Imaging Ltd
AU:OIL
Scientific & Technical Instruments 70.98%
Structural Monitoring Systems Plc
AU:SMN
Scientific & Technical Instruments 0.00%
Dorsavi Ltd
AU:DVL
Scientific & Technical Instruments 57.75%

Annual Asset Resilience Ratio for Novanta Inc (1998–2017)

The table below shows the annual Asset Resilience Ratio data for Novanta Inc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2017-12-31 0.00% $0.00 $726.70 Million --
2016-12-31 0.00% $0.00 $425.64 Million --
2015-12-31 0.00% $0.00 $416.05 Million --
2014-12-31 0.00% $0.00 $397.62 Million --
2013-12-31 0.00% $0.00 $378.81 Million --
2012-12-31 0.00% $0.00 $337.46 Million --
2011-12-31 0.00% $0.00 $348.50 Million --
2007-12-31 -0.01% $-46.00K $440.21 Million -7.18pp
2005-12-31 7.16% $26.76 Million $373.44 Million +6.39pp
2004-12-31 0.78% $3.00 Million $386.16 Million -12.04pp
2003-12-31 12.82% $39.56 Million $308.60 Million +3.06pp
2002-12-31 9.76% $29.00 Million $297.09 Million -3.17pp
2001-12-31 12.93% $43.54 Million $336.69 Million +8.29pp
2000-12-31 4.64% $20.02 Million $431.18 Million +2.12pp
1999-12-31 2.52% $7.30 Million $289.70 Million +1.93pp
1998-12-31 0.59% $900.00K $152.50 Million --
pp = percentage points

About Novanta Inc

NASDAQ:NOVT USA Scientific & Technical Instruments
Market Cap
$5.39 Billion
Market Cap Rank
#3434 Global
#1191 in USA
Share Price
$151.43
Change (1 day)
-2.39%
52-Week Range
$99.22 - $168.59
All Time High
$186.20
About

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets la… Read more